No drug or anti-viral treatment for COVID-19 has yet been approved by the United States Food and Drug Administration.
However, there is one potential treatment that researchers and physicians find promising: convalescent plasma donation. Some call the plasma “liquid gold.”
Across the country, medical trials are underway testing the procedure, which involves transfusing the blood from a COVID-19 survivor into a current COVID-19 patient.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
